After a successful demerger from GlaxoSmithKline Pc, Haleon Plc, formed in July 2022, continues to lead the consumer health industry, supported by its power brands. While North America is a key region, Asia Pacific, and the Middle East and Africa have provided significant gains.. As Rx-to-OTC switches dry up, Haleon will continue to look for strategic investments to grow inorganically. There are opportunities to expand in preventative health outside its Caltrate and Centrum brands.
Files are delivered directly into your account soon after payment is received and any tax certification is verified (where applicable).
This report comes in PPT.
Euromonitor International's report on Haleon plc delivers a detailed strategic analysis of the company's business, examining its performance in the Consumer Health market and the global economy. Company and market share data provide a detailed look at the financial position of Haleon plc, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Haleon plc.
Euromonitor International's company profile reports are written by our Consumer Health research team, a dedicated group of analysts that knows the industry inside and out. Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.
It is the aggregation of OTC, Vitamins and Dietary Supplements (VDS), Sports Nutrition, and Weight Management and WellbeingSee All of Our Definitions
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!